Who
Brian J. Caveney
EVP, Pres of BLS, CMO & CSO
Company insider
Files Form 4 as: EVP, Pres of BLS, CMO & CSO, Labcorp Holdings.
In numbers
- Trades disclosed
- 157
- Buys
- 2
- Sells
- 2
- Bought
- $20K
- Sold
- $1.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Sep 2017
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —9,304 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $1.1M4,042 at $268.38 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —1,986 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $232K863 at $268.38 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —9,304 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $1.1M4,042 at $268.38 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —1,986 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $232K863 at $268.38 | filing |
| 24 Feb 2026filed 26 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $429K1,500 at $286.31 | filing |
| 24 Feb 2026filed 26 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $429K1,500 at $286.31 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —740 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $61K211 at $289.89 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —740 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —740 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —740 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $61K211 at $289.89 | filing |
| 10 Feb 2026filed 12 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —6,100 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —2,020 at $0.00 | filing |
News
Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthLH · prnewswire.com · 15 Oct 2026Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill?LH · insidermonkey.com · 12 Oct 2026
0 headlines in the last 90 days name Brian J. Caveney; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.